To ascertain that our cell lines expressed LDLR and were representative of results obtained from IHC of adult and paediatric TMAs, and therefore amenable to utilize as future in vitro models to test LDLR-targeted nanoparticle uptake/retention, expression levels were examined in three GBM cell lines. This evidence concerns the gene LDLR and glioblastoma.